Navigation Links


Coming at Biology News

Late peak may have prevented severe flu season from becoming worse

The 2004-2005 flu season was at least as severe as the 2003-2004 season, but peaked later according to data from Solucient, a leading provider of healthcare information. This later peak may have prevented the most recent flu season from being even worse. A flu season's severity is reflected in hospital admissions for community-acquired pneumonia (CAP), one of the most common complications...

Heal thyself: Systems biology model reveals how cells avoid becoming cancerous

Researchers at the University of California, San Diego and three other institutions have described for the first time a web of inter-related responses that cells use to avoid becoming diseased or cancerous after being exposed to a powerful chemical mutagen. The group led by UCSD bioengineering professor Trey Ideker describe in the May 19 issue of Science an elaborate system of gene control that...

Coming soon: 3-D imaging that flies 'through' and 'around' cancer

Stanford University researchers demonstrated for the first time the ability to create 3-D positron emission tomography (PET)/computed tomography (CT) images for "fly-through" and "fly-around viewing" of cancer in the lungs and colon, according to a study in the July issue of the Journal of Nuclear Medicine. This powerful ability to meld functional data with accurate anatomical information...

No-mow grass may be coming to your yard soon

For anyone tethered to a lawnmower, the Holy Grail of horticultural accomplishment would be grass that never grows but is always green. Now, that vision of suburban bliss -- and more -- seems plausible as scientists have mapped a critical hormone signaling pathway that regulates the stature of plants. In addition to lawns that rarely require mowing, the finding could also enable the devel...

New technologies coming too fast for Indian farmers

The arrival of genetically modified crops has added another level of complexity to farming in the developing world, says a sociocultural anthropologist at Washington University in St. Louis. Glenn D. Stone, Ph.D., professor of anthropology and of environmental studies, both in Arts & Sciences, at Washington University in St. Louis, has completed the first detailed anthropological field...
Coming at Biology Products
Coming at Biology Technology

Telecom issues are among focus of upcoming western Wisconsin conference

It will be part of the , which will build upon discussions at a December 2004 kickoff luncheo...

Wireless wizardry coming to the small screen

With an estimated 2.5 billion mobile phones in use in over 210 countries worldwide, according to<a href="http://www.gsmworld.com/news/statistics/pdf/gsma_stat...

Federal grant-winning tips coming to Milwaukee

Firms in the entrepreneurial sector are encouraged to attend the from Nov...

Extreme Entrepreneur Tour coming to Fox Valley

To fill this need, will host a "bus load of young, millionaire en...

DEMO 2006: A sea change is coming

T...

More>>

Coming at Medicine News

Turkey becoming epicenter for bird flu

Bird flu virus which has caused 76 deaths in Southeast Asia seems to have shifted its infection to Turkey which has infected 18 people in Turkey. The city of Van in eastern Turkey has experienced three deaths // due to bird flu and all of them got the virus from poultry. The people infected with the bird flu virus are treated using a combination of antibiotics, bird flu anti flu drug Tamiflu and...

Overcoming actively may help in breast cancer

According to new review proposes that having a good coping style helps women to deal positively with breast cancer. There is much debate over whether mental attitude makes a difference in the fight against cancer. Researchers in the US have been looking// at several studies and they conclude that stress, mental outlook and coping style are all relevant to key biological factors like immune functi...

Spine Surgeries becoming less painful

The number of people suffering from spine problems is on the rise; the most common of them being a herniated disc and spinal canal stenosis. Herniated disc is more common in the age group of 25 to 35 years while spinal canal stenosis is common among// older people. Hitherto, both these disorders were treated through conventional spine surgeries which required an incision of about 12cms to be made...

Overcoming Chronic Fatigue

Researchers say 85 percent to 90 percent of the people living with chronic fatigue are undiagnosed. Symptoms of CFS include fatigue, muscle pain, insomnia and impaired memory. It's a difficult disease to diagnose, and there's no cure. But for the 1.3 million Americans who suffer from chronic fatigue syndrome, or CFS for short, a drug commonly used in cancer patients may help them get back a...

New Vaccine for SARS Coming Soon

A new study shows a vaccine made from the common cold virus may induce the immune system to help fight the SARS virus.//Researchers from the Centers for Disease Control and Prevention injected six monkeys with a genetically altered cold virus that is similar to parts of the SARS coronavirus. A new form of the coronavirus, called SARS-CoV, was discovered earlier this year. The monkeys were given...

More>>

Coming at Medicine Products
Coming at Medicine Technology

Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois

NEW YORK, June 22, 2007 /PRNewswire-FirstCall/ -- KeryxBiopharmaceuticals, Inc. today announced that abstracts related toSulonex(TM) (sulodexide oral gelcap) have been selected forpublication or presentation during the poster sessions scheduled totake place at the upcoming American Diabetes Association (ADA) 67thAnnual Scientific Sessions and exposition at the McCormick PlaceLakeside Cen...

Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings

HASBROUCK HEIGHTS, NJ (June 21, 2007) Nymox PharmaceuticalCorporation (NASDAQ: NYMX) today announced that detailed resultsfrom the Company’s recently completed studies of NX-1207 forbenign prostatic hyperplasia (BPH) will be presented at a series ofupcoming U.S. urology meetings, beginning in September at the SouthCentral American Urological Association Meeting in ColoradoSprings....

Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings

HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Jun 21, 2007 - NymoxPharmaceutical Corporation (NASDAQ: NYMX) today announced thatdetailed results from the Company's recently completed studies ofNX-1207 for benign prostatic hyperplasia (BPH) will be presented ata series of upcoming U.S. urology meetings, beginning in Septemberat the South Central American Urological Association Meeting inColorado...

Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 6, 2007 - CombinatoRx,Incorporated (NASDAQ: CRXX), today announced that data from itsrandomized, blinded, placebo-controlled phase 2 clinical trials ofCRx-102 in patients with osteoarthritis (OA) and rheumatoidarthritis (RA) will be featured at the European League againstRheumatism (EULAR) Annual Congress of Rheumatology meeting, June13-16, 2007 in Bar...

Introgen and Clinical Collaborators to Report New Results with Advanced-Stage Cancer Therapies at Upcoming Medical Meetings

AUSTIN, Texas--(BUSINESS WIRE)--May 29, 2007 - IntrogenTherapeutics, Inc. (NASDAQ:INGN) and the Company's clinicalcollaborators will report updated Phase 2 clinical trial resultsfor its lead cancer therapy product candidates at the upcomingannual meetings of The American Society of Clinical Oncology (ASCO)in Chicago and the American Society of Gene Therapy (ASGT) inSeattle. "We have a st...

More>>

Other TagsSansAwaitPowePowePowePowePowe
(Date:8/21/2008)... IL, Aug. 21 /PRNewswire-FirstCall/ - SXC Health S...SXCI , TSX: SXC), a leading provider of,pharmacy b...hierer,President and CEO, and Jeff Park, CFO, wil...hcare Conference at the Four Seasons Hotel in Bost...ace on Wednesday, September,3, 2008 at 2:40 pm ET....
(Date:8/21/2008)... Flu Vaccination Awareness Campaign...Electing a President is Not the Only Important Cho...aithersburg, MD (PRWEB) August 21, 2008 -- A new s...at vaccination ranks next to last among things the...influenza virus. Although public health guidelines...
(Date:8/21/2008)...ous Coalition for Reproductive Choice at the Democ...RNewswire-USNewswire/ -- RCRC -- the Religious,Coa...ents at the Democratic,National Convention to high...s in the campaign. RCRC,s president, The Reverend ...d is also available for media,interviews. RCRC is ...
(Date:8/21/2008)...IA BEACH, Va., Aug. 21, 2008 /PRNewswire/ -- The A...p. Sylvester Turner of Houston has,been honored wi...is part of the AMERIGROUP Foundation,s national pr...rts by government and community,leaders in improvi...t our,nation., "Our goal is to work together with...
Breaking Medicine News(10 mins):Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 2Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 3Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 4Health News:Survey Shows Parents' Best Intentions Out of Step With Expert Recommendations in Protecting Kids From Flu 5Health News:Texas State Rep. Sylvester Turner Honored as 'Champion for Children' by The AMERIGROUP Foundation 2
(Date:8/20/2008)...ileCampus(TM) Wireless Data Communications Link Sc... Faculty, WALL, N.J., Aug. 20 /PRNewswire-FirstCa...ard: BKYI), a leader in finger-based biometric,ide...today announced the,availability of MobileSRO(TM) ...rt and management solutions for K-12 schools and h...
(Date:8/20/2008)...Capital Leads Round with Additional Funding by Syn...ing Investors Including Lockheed Martin, GE Sec...RK, Aug. 20 /PRNewswire/ -- Clear(R), the fast pas...in venture funding. Led by new investor,Spark Capi...ncom Venture,Partners, and existing investors Lock...
(Date:8/20/2008)...mony watermelon? How about a strawberry-flavored b...cal School at Houston say the day may be coming wh...sponsible for flavors in fruits and vegetables. In...ly pest control. , In the advance online publica...istant Professor C.S. Raman, Ph.D., and his collea...
(Date:8/20/2008)...nd. - Engineers have created a tiny motorized ,po...imilar devices being ,developed for applications ..., powerful computer hard drives. , The device, c...,"nanoscale manipulator" that precisely moves or ... be used in watery environments for probing ,biol...
Breaking Biology News(10 mins):BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 2BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 3Clear(R) Secures $44.4 Million in Venture Funding 2Clear(R) Secures $44.4 Million in Venture Funding 3Biochemists manipulate fruit flavor enzymes 2New 'nano-positioners' may have atomic-scale precision 2New 'nano-positioners' may have atomic-scale precision 3Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 1Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 2Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 3Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 4Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2259 5Hodgkin Lymphoma Kids Face Greater Risk of Future Problems 20754 1Hodgkin Lymphoma Kids Face Greater Risk of Future Problems 20754 2Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 1Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 2Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 3Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 4Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K mTOR Inhibitor XL765 at ASCO 2258 5Phase III Study of Abbotts Investigational TriLipix 28TM 29 in Combination With AstraZenecas CRESTOR 28R 29 Meets Primary Endpoints on Key Lipids 2257 1Phase III Study of Abbotts Investigational TriLipix 28TM 29 in Combination With AstraZenecas CRESTOR 28R 29 Meets Primary Endpoints on Key Lipids 2257 2Phase III Study of Abbotts Investigational TriLipix 28TM 29 in Combination With AstraZenecas CRESTOR 28R 29 Meets Primary Endpoints on Key Lipids 2257 3Phase III Study of Abbotts Investigational TriLipix 28TM 29 in Combination With AstraZenecas CRESTOR 28R 29 Meets Primary Endpoints on Key Lipids 2257 4
Other Contentsshigellosissplintssplintsshinshinglesshinglesstaturestaturestaturestatureshouldershouldershouldershouldershouldershouldershuntshuntshuntsicksicksicksick